Skip to main content

Toronto CBD Firm Taps Ex-Acting U.S. Attorney General Whitaker For New Legal Advisor Role

Toronto-based CBD company Alternate Health Corp has hired Matthew Whitaker, former acting U.S. Attorney General, and his law firm Graves Garrett to serve as outside counsel. Best known for his brief tenure as U.S. Acting Attorney General after President Trump’s firing of firebrand cannabis foe Jeff Sessions, Whitaker generated controversy for his alleged ties to Trump and his comments about the Robert Mueller probe of Russian interference into the 2016 U.S. presidential election. In February 2019, Whitaker left his position after serving for only three months.

His appointment comes at a critical moment for Alternate Health, which recently stated that it was pivoting away from marijuana to focus more on hemp-derived CBD. Commenting on the high-profile hire, Alternate Health President Dr. Robert Blaine noted in a public statement how Whitaker is coming on board during a key inflection point for his company, currently divesting its cannabis assets.

“The legal environment surrounding CBD is rapidly evolving and it is essential that Alternate Health stays at the forefront of new government and FDA regulations,” he said. “We believe his experience in government and the Department of Justice is a significant asset as we move forward.”

Whitaker, who also served as Chief of Staff to then Attorney General Sessions from September 2017 to November 2018, is looking forward to his new role as a key legal advisor to Alternate Health. “I think there is serious potential in the CBD industry,” he said in a statement, “and everyone at Alternate Health will work hard to be a leader in the industry.”

According to Alternate Health, Whitaker will “tackle key issues” for the company. Foremost among them is “an investigation into certain actions in Canada by a California-based competitor.” When not conducting portentous probes into the misdeeds of unnamed rival companies, Whitaker’s other duties will include coordinating legal matters and developing Alternate Health’s “legal strategy as the company expands into new markets.”

Whitaker bears the distinction of being the latest high-ranking Republican to take his knowledge and juridical prowess to the cannabis/CBD/hemp market. John Boehner, former Speaker of the House, has become a very vocal champion of the space, even sitting on the board of Acreage Holdings, a New York-based multistate cannabis operator.

Whitaker’s skills working (or haggling) with D.C. lawmakers may be put to good use in his new position. Said Howard Mann, Alternate Health CEO, in a statement: “His knowledge and experience open doors at many of the most important institutions concerning our industry. I am also impressed with his toughness and tenacity he developed as a prosecutor, enforcing state and federal laws, examining alleged legal violations and setting a standard of fairness and justice.”

In addition to his serving as Acting U.S. Attorney General, Whitaker has donned other hats in the legal realm. This includes working as the U.S. Attorney for the Southern District of Iowa. In addition to his affiliation with the Graves Garrett law firm, Whitaker is also the managing director for Axiom Strategies/Clout Public Affairs.

Original Article Source: https://www.forbes.com/sites/irisdorbian/2019/08/28/toronto-cbd-firm-taps-ex-acting-u-s-attorney-general-whitaker-for-new-legal-advisor-role/

Comments

Post a Comment

Popular posts from this blog

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...
Post a Comment
Read more

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...
Post a Comment
Read more

New York Governor Will Visit Legal Marijuana States To Take Lessons Back Home

One week after bills to decriminalize marijuana in Virginia were passed by both the House and Senate , they advanced again on Wednesday in committee votes, where they were revised in an effort to ease the path to the governor’s desk. The goal was to make the language of the bills identical, with lawmakers hoping to streamline the process by avoiding sending differing pieces of decriminalization legislation to a bicameral conference committee to resolve differences. The House of Delegates and Senate were under pressure to approve their respective versions of decriminalization ahead of a crossover deadline last week. After clearing floor votes in their respective chambers, the Senate-passed bill was sent to the House Court of Justice Committee, while the House’s legislation was referred to the Senate Judiciary Committee. Those panels amended the bills and advanced them on Wednesday, with senators voting 10-4 to advance the revised legislation and delegates voting 8-5. However, the Sen...
Post a Comment
Read more